MED15-BCL2L13 Fusion FISH Probe
The MED15-BCL2L13 Fusion FISH Probe is used to confirm a fusion of the MED15 and BCL2L13 genes. The fusion of the MED15 and BCL2L13 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MED15-BCL2L13-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MED15-BCL2L13-20-AQAQ | 20 (40 μL) | 200 μL |
|
BCL2L13 Gene Summary
This gene encodes a mitochondrially-localized protein with conserved B-cell lymphoma 2 homology motifs. Overexpression of the encoded protein results in apoptosis. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]
Gene Name: BCL2 Like 13
Chromosome: CHR22: 18121484 -18211989
Locus: 22q11.21
MED15 Gene Summary
The protein encoded by this gene is a subunit of the multiprotein complexes PC2 and ARC/DRIP and may function as a transcriptional coactivator in RNA polymerase II transcription. This gene contains stretches of trinucleotide repeats and is located in the chromosome 22 region which is deleted in DiGeorge syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Gene Name: Mediator Complex Subunit 15
Chromosome: CHR22: 20861885 -20941919
Locus: 22q11.21
Gene Diseases
The MED15 BCL2L13 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|